市場調査レポート

商品コード

1771643

マルチオミクス市場の市場規模、シェア、動向分析レポート：製品とサービス別、タイプ別、プラットフォーム別、用途別、最終用途別、地域別、セグメント予測、2025年～2033年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日: 2025年06月16日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 883,396円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,031,866円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,328,806円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

マルチオミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマルチオミクス市場規模は2033年までに98億1,000万米ドルに達し、2025年から2033年までのCAGRは15.33%で拡大すると推定されています。

オミックス技術のコスト低下、民間および公的企業からの投資や資金調達の増加などの要因が市場を牽引すると予想されます。また、製薬会社やバイオテクノロジー企業、学術研究機関からの需要増加による市場競争の激化も、予測期間中の市場成長を促進すると予測されています。

技術の向上により、オミックス技術のコストは低下し、研究者がデータセットにアクセスしやすくなり、結果的に市場成長を促進すると予想されます。企業はコスト削減のために技術の進歩に注力しています。例えば、アマゾン・ウェブ・サービスは2022年11月にアマゾン・オミックス・サービスを発表しました。このサービスは、バイオインフォマティクスを考慮したストレージオプションを利用して生のシーケンスデータを保存し、コストを削減します。このように、コストが低下することで、研究者や臨床医がオミックス技術にアクセスしやすくなると予想されます。このようなコスト削減は、マルチオミクス・アプローチの採用を増加させると予想されます。

民間および公的参加者からの投資や資金提供の増加は、マルチオミクス製品やサービスの需要を押し上げると予想されます。様々な企業がマルチオミクスのプラットフォームや技術の開発に多額の投資を行っています。例えば、2022年1月、ロシュはバイオテクノロジー企業であるFreenomeに2億9,000万米ドルを投資しました。この投資は、早期がん発見のためのマルチオミクス・プラットフォームを加速させるために使われました。また、2023年5月には、MultiOmic Health社が精密治療薬発見プラットフォームを構築するために620万米ドルの資金調達を完了しました。このように、資金調達と投資の増加は、市場における様々な新規プラットフォームと製品の開発につながると予想されます。

市場関係者が革新的な製品やサービスの開発に重点を置くようになっていることも、市場の需要を前進させる重要な要因です。さまざまな企業が、競争の激化に対応するため、斬新なプラットフォームを開発しています。例えば、2023年2月、Via Scientific, Inc.は、マルチオミクス研究中の複雑なデータと分析作業の自動化をサポートするマルチオミクスアクセラレータプラットフォーム、鋳造を発表しました。このような製品発表は、予測期間中、業界を牽引すると予想されます。

マルチオミクス市場レポートハイライト

製品とサービスセグメントに基づくと、2024年の市場収益シェアは最大。このセグメントの成長は、開発急増と製品発売数によって牽引されると予測されます。
タイプ別では、バルクマルチオミクスセグメントが2024年に最大の市場収益シェアを占める。一方、シングルセルマルチオミクスは、複雑な生物学システムを理解するためのシングルセルマルチオミクスの需要増加により、予測期間中17.8%のCAGRで最も速い成長が見込まれます。
プラットフォーム別では、ゲノミクスが2024年の売上シェア40.63%で市場を独占しています。この成長は、このセグメントで利用可能な製品数が多いことに起因しています。
用途別では、がん分野が2024年に最大の市場収益シェアを占めました。がんの罹患率の上昇とがんに対するマルチオミクスの使用の増加が、このセグメントの成長を促進すると予測されています。
最終用途別では、学術・研究機関セグメントが2024年に最大の市場収益シェアを占めました。これとは対照的に、製薬・バイオテクノロジー企業は、創薬と開発を加速するためのマルチオミクスに対する需要の増加により、最も速い成長が見込まれています。
北米は2024年に48.76%の収益シェアで世界市場を独占したが、これは同地域に主要な市場プレーヤーが存在するためです。

セグメントダッシュボード
世界マルチオミクス市場プラットフォーム変動分析
世界のマルチオミクス市場規模と動向分析（プラットフォーム別、2021～2033年）
ゲノミクス
トランスクリプトミクス
プロテオミクス
メタボロミクス
統合オミクスプラットフォーム

第7章マルチオミクス市場：用途のビジネス分析

セグメントダッシュボード
世界マルチオミクス市場用途変動分析
世界のマルチオミクス市場規模と動向分析（用途別、2021～2033年）
細胞生物学
腫瘍学
神経学
免疫学

第8章マルチオミクス市場：最終用途のビジネス分析

セグメントダッシュボード
世界マルチオミクス市場の最終用途変動分析
世界のマルチオミクス市場規模と動向分析（最終用途別、2021～2033年）
学術調査機関
製薬・バイオテクノロジー企業
その他

第9章マルチオミクス市場：地域のビジネス分析

地域ダッシュボード
市場規模と予測および動向分析、2021～2033年
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第10章競合情勢

参入企業
戦略マッピング
企業市況分析、2024年
参入企業の概要
- BD
- Thermo Fisher Scientific Inc.
- Illumina, Inc
- Danaher
- PerkinElmer Inc.
- Shimadzu Corporation
- Bruker
- QIAGEN
- Agilent Technologies, Inc.
- BGI

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 4 Global multiomics market, by type, 2021 - 2033 (USD Million)
Table 5 Global multiomics market, by platform, 2021 - 2033 (USD Million)
Table 6 Global multiomics market, by application, 2021 - 2033 (USD Million)
Table 7 Global multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 8 Global multiomics market, by region, 2021 - 2033 (USD Million)
Table 9 North America multiomics market, by country, 2021 - 2033 (USD Million)
Table 10 North America multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 11 North America multiomics market, by type, 2021 - 2033 (USD Million)
Table 12 North America multiomics market, by platform, 2021 - 2033 (USD Million)
Table 13 North America multiomics market, by application, 2021 - 2033 (USD Million)
Table 14 North America multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 15 U.S. multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 16 U.S. multiomics market, by type, 2021 - 2033 (USD Million)
Table 17 U.S. multiomics market, by platform, 2021 - 2033 (USD Million)
Table 18 U.S. multiomics market, by application, 2021 - 2033 (USD Million)
Table 19 U.S. multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 20 Canada multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 21 Canada multiomics market, by type, 2021 - 2033 (USD Million)
Table 22 Canada multiomics market, by platform, 2021 - 2033 (USD Million)
Table 23 Canada multiomics market, by application, 2021 - 2033 (USD Million)
Table 24 Canada multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 25 Mexico multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 26 Mexico multiomics market, by type, 2021 - 2033 (USD Million)
Table 27 Mexico multiomics market, by platform, 2021 - 2033 (USD Million)
Table 28 Mexico multiomics market, by application, 2021 - 2033 (USD Million)
Table 29 Mexico multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 30 Europe multiomics market, by country, 2021 - 2033 (USD Million)
Table 31 Europe multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 32 Europe multiomics market, by type, 2021 - 2033 (USD Million)
Table 33 Europe multiomics market, by platform, 2021 - 2033 (USD Million)
Table 34 Europe multiomics market, by application, 2021 - 2033 (USD Million)
Table 35 Europe multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 36 UK multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 37 UK multiomics market, by type, 2021 - 2033 (USD Million)
Table 38 UK multiomics market, by platform, 2021 - 2033 (USD Million)
Table 39 UK multiomics market, by application, 2021 - 2033 (USD Million)
Table 40 UK multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 41 Germany multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 42 Germany multiomics market, by type, 2021 - 2033 (USD Million)
Table 43 Germany multiomics market, by platform, 2021 - 2033 (USD Million)
Table 44 Germany multiomics market, by application, 2021 - 2033 (USD Million)
Table 45 Germany multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 46 France multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 47 France multiomics market, by type, 2021 - 2033 (USD Million)
Table 48 France multiomics market, by platform, 2021 - 2033 (USD Million)
Table 49 France multiomics market, by application, 2021 - 2033 (USD Million)
Table 50 France multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 51 Italy multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 52 Italy multiomics market, by type, 2021 - 2033 (USD Million)
Table 53 Italy multiomics market, by platform, 2021 - 2033 (USD Million)
Table 54 Italy multiomics market, by application, 2021 - 2033 (USD Million)
Table 55 Italy multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 56 Spain multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 57 Spain multiomics market, by type, 2021 - 2033 (USD Million)
Table 58 Spain multiomics market, by platform, 2021 - 2033 (USD Million)
Table 59 Spain multiomics market, by application, 2021 - 2033 (USD Million)
Table 60 Spain multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 61 Denmark multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 62 Denmark multiomics market, by type, 2021 - 2033 (USD Million)
Table 63 Denmark multiomics market, by platform, 2021 - 2033 (USD Million)
Table 64 Denmark multiomics market, by application, 2021 - 2033 (USD Million)
Table 65 Denmark multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 66 Sweden multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 67 Sweden multiomics market, by type, 2021 - 2033 (USD Million)
Table 68 Sweden multiomics market, by platform, 2021 - 2033 (USD Million)
Table 69 Sweden multiomics market, by application, 2021 - 2033 (USD Million)
Table 70 Sweden multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 71 Norway multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 72 Norway multiomics market, by type, 2021 - 2033 (USD Million)
Table 73 Norway multiomics market, by platform, 2021 - 2033 (USD Million)
Table 74 Norway multiomics market, by application, 2021 - 2033 (USD Million)
Table 75 Norway multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 76 Asia Pacific multiomics market, by country, 2021 - 2033 (USD Million)
Table 77 Asia Pacific multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 78 Asia Pacific multiomics market, by type, 2021 - 2033 (USD Million)
Table 79 Asia Pacific multiomics market, by platform, 2021 - 2033 (USD Million)
Table 80 Asia Pacific multiomics market, by application, 2021 - 2033 (USD Million)
Table 81 Asia Pacific multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 82 Japan multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 83 Japan multiomics market, by type, 2021 - 2033 (USD Million)
Table 84 Japan multiomics market, by platform, 2021 - 2033 (USD Million)
Table 85 Japan multiomics market, by application, 2021 - 2033 (USD Million)
Table 86 Japan multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 87 China multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 88 China multiomics market, by type, 2021 - 2033 (USD Million)
Table 89 China multiomics market, by platform, 2021 - 2033 (USD Million)
Table 90 China multiomics market, by application, 2021 - 2033 (USD Million)
Table 91 China multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 92 India multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 93 India multiomics market, by type, 2021 - 2033 (USD Million)
Table 94 India multiomics market, by platform, 2021 - 2033 (USD Million)
Table 95 India multiomics market, by application, 2021 - 2033 (USD Million)
Table 96 India multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 97 Australia multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 98 Australia multiomics market, by type, 2021 - 2033 (USD Million)
Table 99 Australia multiomics market, by platform, 2021 - 2033 (USD Million)
Table 100 Australia multiomics market, by application, 2021 - 2033 (USD Million)
Table 101 Australia multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 102 Thailand multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 103 Thailand multiomics market, by type, 2021 - 2033 (USD Million)
Table 104 Thailand multiomics market, by platform, 2021 - 2033 (USD Million)
Table 105 Thailand multiomics market, by application, 2021 - 2033 (USD Million)
Table 106 Thailand multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 107 South Korea multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 108 South Korea multiomics market, by type, 2021 - 2033 (USD Million)
Table 109 South Korea multiomics market, by platform, 2021 - 2033 (USD Million)
Table 110 South Korea multiomics market, by application, 2021 - 2033 (USD Million)
Table 111 South Korea multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 112 Latin America multiomics market, by country, 2021 - 2033 (USD Million)
Table 113 Latin America multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 114 Latin America multiomics market, by type, 2021 - 2033 (USD Million)
Table 115 Latin America multiomics market, by platform, 2021 - 2033 (USD Million)
Table 116 Latin America multiomics market, by application, 2021 - 2033 (USD Million)
Table 117 Latin America multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 118 Brazil multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 119 Brazil multiomics market, by type, 2021 - 2033 (USD Million)
Table 120 Brazil multiomics market, by platform, 2021 - 2033 (USD Million)
Table 121 Brazil multiomics market, by application, 2021 - 2033 (USD Million)
Table 122 Brazil multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 123 Argentina multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 124 Argentina multiomics market, by type, 2021 - 2033 (USD Million)
Table 125 Argentina multiomics market, by platform, 2021 - 2033 (USD Million)
Table 126 Argentina multiomics market, by application, 2021 - 2033 (USD Million)
Table 127 Argentina multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 128 Middle East & Africa multiomics market, by country, 2021 - 2033 (USD Million)
Table 129 Middle East & Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 130 Middle East & Africa multiomics market, by type, 2021 - 2033 (USD Million)
Table 131 Middle East & Africa multiomics market, by platform, 2021 - 2033 (USD Million)
Table 132 Middle East & Africa multiomics market, by application, 2021 - 2033 (USD Million)
Table 133 Middle East & Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 134 South Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 135 South Africa multiomics market, by type, 2021 - 2033 (USD Million)
Table 136 South Africa multiomics market, by platform, 2021 - 2033 (USD Million)
Table 137 South Africa multiomics market, by application, 2021 - 2033 (USD Million)
Table 138 South Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia multiomics market, by type, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia multiomics market, by platform, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia multiomics market, by application, 2021 - 2033 (USD Million)
Table 143 Saudi Arabia multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 144 UAE multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 145 UAE multiomics market, by type, 2021 - 2033 (USD Million)
Table 146 UAE multiomics market, by platform, 2021 - 2033 (USD Million)
Table 147 UAE multiomics market, by application, 2021 - 2033 (USD Million)
Table 148 UAE multiomics market, by end-use, 2021 - 2033 (USD Million)
Table 149 Kuwait multiomics market, by product & service, 2021 - 2033 (USD Million)
Table 150 Kuwait multiomics market, by type, 2021 - 2033 (USD Million)
Table 151 Kuwait multiomics market, by platform, 2021 - 2033 (USD Million)
Table 152 Kuwait multiomics market, by application, 2021 - 2033 (USD Million)
Table 153 Kuwait multiomics market, by end-use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Multiomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Multiomics market driver analysis
Fig. 12 Multiomics market restraint analysis
Fig. 13 Multiomics market: Porter's analysis
Fig. 14 Multiomics market: PESTEL analysis
Fig. 15 Multiomics market: Product & service outlook and key takeaways
Fig. 16 Multiomics market: Product & service market share analysis, 2024 - 2033
Fig. 17 Global multiomics by products market, 2021 - 2033 (USD Million)
Fig. 18 Global multiomics by instruments market, 2021 - 2033 (USD Million)
Fig. 19 Global multiomics by consumables market, 2021 - 2033 (USD Million)
Fig. 20 Global multiomics by software market, 2021 - 2033 (USD Million)
Fig. 21 Global multiomics by services market, 2021 - 2033 (USD Million)
Fig. 22 Multiomics market: Type outlook and key takeaways
Fig. 23 Multiomics market: Type market share analysis, 2024 - 2033
Fig. 24 Global single-cell multiomics by men market, 2021 - 2033 (USD Million)
Fig. 25 Global multiomics by bulk multiomics market, 2021 - 2033 (USD Million)
Fig. 26 Multiomics market: Platform outlook and key takeaways
Fig. 27 Multiomics market: Platform market share analysis, 2024 - 2033
Fig. 28 Global multiomics by genomics market, 2021 - 2033 (USD Million)
Fig. 29 Global multiomics by transcriptomics market, 2021 - 2033 (USD Million)
Fig. 30 Global multiomics by proteomics market, 2021 - 2033 (USD Million)
Fig. 31 Global multiomics by metabolomics market, 2021 - 2033 (USD Million)
Fig. 32 Global multiomics by integrated omics platforms market, 2021 - 2033 (USD Million)
Fig. 33 Multiomics market: Application outlook and key takeaways
Fig. 34 Multiomics market: Application market share analysis, 2024 - 2033
Fig. 35 Global multiomics by cell biology market, 2021 - 2033 (USD Million)
Fig. 36 Global multiomics by oncology market, 2021 - 2033 (USD Million)
Fig. 37 Global multiomics by neurology market, 2021 - 2033 (USD Million)
Fig. 38 Global multiomics by immunology market, 2021 - 2033 (USD Million)
Fig. 39 Multiomics market: End-use outlook and key takeaways
Fig. 40 Multiomics market: End-use market share analysis, 2024 - 2033
Fig. 41 Global multiomics by academic and research institutes market, 2021 - 2033 (USD Million)
Fig. 42 Global multiomics by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 43 Global multiomics by others market, 2021 - 2033 (USD Million)
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada multiomics market, 2021 - 2033 (USD Million)
Fig. 50 Europe multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 UK key country dynamics
Fig. 52 UK multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 Germany key country dynamics
Fig. 54 Germany multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 55 France key country dynamics
Fig. 56 France multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 57 Italy key country dynamics
Fig. 58 Italy multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 59 Spain key country dynamics
Fig. 60 Spain multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 65 Norway key country dynamics
Fig. 66 Norway multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 67 Asia-Pacific multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 68 Japan key country dynamics
Fig. 69 Japan multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 70 China key country dynamics
Fig. 71 China multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 72 India key country dynamics
Fig. 73 India multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 74 Australia key country dynamics
Fig. 75 Australia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 76 Thailand key country dynamics
Fig. 77 Thailand multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 78 South Korea key country dynamics
Fig. 79 South Korea multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 80 Latin America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 81 Brazil key country dynamics
Fig. 82 Brazil multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 83 Mexico key country dynamics
Fig. 84 Mexico multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 87 MEA multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait multiomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 96 Key company categorization
Fig. 97 Company market positioning
Fig. 98 Market participant categorization
Fig. 99 Strategy framework

Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Type
- 1.2.3. Platform
- 1.2.4. Application
- 1.2.5. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

4.1. Segment Dashboard
4.2. Global Multiomics Market Product & Service Movement Analysis
4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Product
- 4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Instruments
  - 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Consumables
  - 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Software
  - 4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Services
- 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

5.1. Segment Dashboard
5.2. Global Multiomics Market Type Movement Analysis
5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Single-cell Multiomics
- 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Bulk Multiomics
- 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

6.1. Segment Dashboard
6.2. Global Multiomics Market Platform Movement Analysis
6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
6.4. Genomics
- 6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Transcriptomics
- 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Proteomics
- 6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Metabolomics
- 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Integrated Omics Platforms
- 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

7.1. Segment Dashboard
7.2. Global Multiomics Market Application Movement Analysis
7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Cell Biology
- 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Oncology
- 7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Neurology
- 7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Immunology
- 7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

8.1. Segment Dashboard
8.2. Global Multiomics Market End-use Movement Analysis
8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
8.4. Academic and Research Institutes
- 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Pharmaceutical & Biotechnology Companies
- 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Others
- 8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
- 9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Europe
- 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Framework
  - 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Framework
  - 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Australia
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. South Korea
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. MEA
- 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Framework
  - 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Framework
  - 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Participant's Overview
- 10.4.1. BD
  - 10.4.1.1. Overview
  - 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Strategic Initiatives
- 10.4.2. Thermo Fisher Scientific Inc.
  - 10.4.2.1. Overview
  - 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Strategic Initiatives
- 10.4.3. Illumina, Inc
  - 10.4.3.1. Overview
  - 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Strategic Initiatives
- 10.4.4. Danaher
  - 10.4.4.1. Overview
  - 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Strategic Initiatives
- 10.4.5. PerkinElmer Inc.
  - 10.4.5.1. Overview
  - 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Strategic Initiatives
- 10.4.6. Shimadzu Corporation
  - 10.4.6.1. Overview
  - 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Strategic Initiatives
- 10.4.7. Bruker
  - 10.4.7.1. Overview
  - 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Strategic Initiatives
- 10.4.8. QIAGEN
  - 10.4.8.1. Overview
  - 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Strategic Initiatives
- 10.4.9. Agilent Technologies, Inc.
  - 10.4.9.1. Overview
  - 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Strategic Initiatives
- 10.4.10. BGI
  - 10.4.10.1. Overview
  - 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Strategic Initiatives

マルチオミクス市場の市場規模、シェア、動向分析レポート：製品とサービス別、タイプ別、プラットフォーム別、用途別、最終用途別、地域別、セグメント予測、2025年～2033年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

マルチオミクス市場の成長と動向：

マルチオミクス市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場の変数、動向、範囲

第4章マルチオミクス市場：製品とサービスのビジネス分析

第5章マルチオミクス市場：タイプのビジネス分析

第6章マルチオミクス市場：プラットフォームのビジネス分析

第7章マルチオミクス市場：用途のビジネス分析

第8章マルチオミクス市場：最終用途のビジネス分析

第9章マルチオミクス市場：地域のビジネス分析

第10章競合情勢

List of Tables

List of Figures

Multiomics Market Growth & Trends:

Multiomics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Multiomics Market: Product & Service Business Analysis

Chapter 5. Multiomics Market: Type Business Analysis

Chapter 6. Multiomics Market: Platform Business Analysis

Chapter 7. Multiomics Market: Application Business Analysis

Chapter 8. Multiomics Market: End-use Business Analysis

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

Chapter 10. Competitive Landscape

マルチオミクス市場の市場規模、シェア、動向分析レポート：製品とサービス別、タイプ別、プラットフォーム別、用途別、最終用途別、地域別、セグメント予測、2025年～2033年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

マルチオミクス市場の成長と動向：

マルチオミクス市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

第4章 マルチオミクス市場：製品とサービスのビジネス分析

第5章 マルチオミクス市場：タイプのビジネス分析

第6章 マルチオミクス市場：プラットフォームのビジネス分析

第7章 マルチオミクス市場：用途のビジネス分析

第8章 マルチオミクス市場：最終用途のビジネス分析

第9章 マルチオミクス市場：地域のビジネス分析

第10章 競合情勢

List of Tables

List of Figures

Multiomics Market Growth & Trends:

Multiomics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Multiomics Market: Product & Service Business Analysis

Chapter 5. Multiomics Market: Type Business Analysis

Chapter 6. Multiomics Market: Platform Business Analysis

Chapter 7. Multiomics Market: Application Business Analysis

Chapter 8. Multiomics Market: End-use Business Analysis

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

Chapter 10. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場の変数、動向、範囲

第4章マルチオミクス市場：製品とサービスのビジネス分析

第5章マルチオミクス市場：タイプのビジネス分析

第6章マルチオミクス市場：プラットフォームのビジネス分析

第7章マルチオミクス市場：用途のビジネス分析

第8章マルチオミクス市場：最終用途のビジネス分析

第9章マルチオミクス市場：地域のビジネス分析

第10章競合情勢